Lindbrook Capital, LLC Xencor Inc Transaction History
Lindbrook Capital, LLC
- $1.09 Billion
- Q4 2024
A detailed history of Lindbrook Capital, LLC transactions in Xencor Inc stock. As of the latest transaction made, Lindbrook Capital, LLC holds 67 shares of XNCR stock, worth $929. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67
Previous 235
71.49%
Holding current value
$929
Previous $4,000
75.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding XNCR
# of Institutions
199Shares Held
73.7MCall Options Held
1.7KPut Options Held
4.2K-
Black Rock Inc. New York, NY11.1MShares$154 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA8.98MShares$125 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.02MShares$111 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.14MShares$85.2 Million6.6% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.04MShares$56 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $828M
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...